SCHEMBL9100044

SCHEMBL9100044

Nc1cc([C]=O)cc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
HSD17B10 Q99714 3/20 0.45
HPGD P15428 2/20 0.45
CYP3A4 P08684 2/20 0.45
TSHR P16473 1/20 0.45
KEAP1 Q14145 1/20 0.45
HPRT1 P00492 1/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
POLB P06746 2/20 0.39
RAD52 P43351 2/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
KDM4E B2RXH2 3/20 0.38
CYP1B1 Q16678 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP1A1 P04798 1/20 0.38
HTT P42858 1/20 0.38
NQO1 P15559 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689378 0.80 CYP1B1 (0.48) ALDH1A1HSD17B10HPGDCYP3A4TSHR
SCHEMBL4078176 0.80 CA1 (0.55) ALDH1A1HSD17B10HPGDCYP3A4TSHR
SCHEMBL7841910 0.76 CA1 (0.46) ALDH1A1HSD17B10HPGDCYP3A4CA1
SCHEMBL9097694 0.76 NQO2 (0.55) ALDH1A1HSD17B10HPGDCA1CA2
SCHEMBL5397734 0.76 CA1 (0.42) ALDH1A1HSD17B10HPGDCYP3A4CA1
SCHEMBL1920437 0.73 CYP1A2 (0.61) ALDH1A1HSD17B10HPGDTSHRHPRT1
SCHEMBL10626407 0.73 CYP1A2 (0.40) ALDH1A1HSD17B10CA1CA2MAPT
SCHEMBL9668753 0.72 NR4A1 (0.53) ALDH1A1HSD17B10HPGDPOLBKDM4E
SCHEMBL29487594 0.72 ALDH1A1 (0.54) ALDH1A1HSD17B10HPGDCYP3A4TSHR
SCHEMBL2153752 0.72 ALDH1A1 (0.54) ALDH1A1HSD17B10HPGDCYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180897-B1 5-FLUOROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-07 EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed